MS vs NRIX · P/E 20, $344.27B cap vs rev $54.5M
Morgan Stanley (MS) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
MS does not have a complete income-statement cache yet.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
MS currently screens at market cap $344.27B and trailing P/E 19.8. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the MS and NRIX stock pages for the full models.
Not investment advice.